KR100593707B1 - Cosmetic Products and their manufacturing methods helping to improve acnegenic and seborrheic skin through anti-microbial action and inhibitory action of sebum secretion. - Google Patents

Cosmetic Products and their manufacturing methods helping to improve acnegenic and seborrheic skin through anti-microbial action and inhibitory action of sebum secretion. Download PDF

Info

Publication number
KR100593707B1
KR100593707B1 KR1020030102337A KR20030102337A KR100593707B1 KR 100593707 B1 KR100593707 B1 KR 100593707B1 KR 1020030102337 A KR1020030102337 A KR 1020030102337A KR 20030102337 A KR20030102337 A KR 20030102337A KR 100593707 B1 KR100593707 B1 KR 100593707B1
Authority
KR
South Korea
Prior art keywords
acne
skin
inci name
extract
sebum
Prior art date
Application number
KR1020030102337A
Other languages
Korean (ko)
Other versions
KR20050071275A (en
Inventor
김은석
김세기
강인오
변미영
Original Assignee
(주) 이지함
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주) 이지함 filed Critical (주) 이지함
Priority to KR1020030102337A priority Critical patent/KR100593707B1/en
Publication of KR20050071275A publication Critical patent/KR20050071275A/en
Application granted granted Critical
Publication of KR100593707B1 publication Critical patent/KR100593707B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/008Preparations for oily skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

본 발명은 피부 표면에 도포됨으로써 5αReductase 의 활성을 저해하여 과잉 피지 분비를 막고 세균 성장을 억제 및 살균하여 여드름 개선 및 과잉 피지 분비로 인한 피부 질환에 치료 효과를 가지는 화장료 조성물 및 그의 제조방법에 관한 것이다. 먼저 유용 성분인 Sepicontrol A5(INCI name : Capryloyl Glycine and Sarcosine and Cinnamomum Zeylanicum Bark Extract)를 D.I Water에 녹인 다음 에틸알코올에 여드름 원인 균주에 대해 항균능을 가지는 Candida bombicola 균주의 Glucose/Methyl rapeseedate 대사산물과 가용화제를 배합한 후 이를 상기 용액에 첨가 가용화 한다. 다음 여기에 Acnet(INCI name : Water and Butylene Glycol and PEG-60 Almond Glycerides and Caprylyl Glycol and Glycerine and Carbomer and Nordihydroguaiaretic Acid and Oleanolic Acid)을 첨가 용해시켜 최종적으로 과잉 피지 분비와 이로 인한 여드름 등의 피부질환에 치료효과를 가지는 화장료 조성물을 만든다. 본 조성물은 기본적으로 항균능을 가지는 성분들로 구성되어 있다. Sepicontrol A5와 Acnet은 여드름의 주원인 균주로 꼽히고 있는 프로피오니박테리움 아크네스(Propionibacterium acnes)에 대하여 탁월한 항균능을 보이며, 본 발명품에서는 그 효과가 다른 성분들과 함께 시너지 효과를 나타내어 항생제인 에리스토마이신 (Erythtomycin)이나 클린다마이신(Clindamycin) 보다도 더 큰 것으로 나타났다.The present invention relates to a cosmetic composition having a therapeutic effect on skin diseases caused by acne improvement and excess sebum secretion by inhibiting the activity of 5αReductase by being applied to the skin surface to prevent excessive sebum secretion and inhibiting and sterilizing bacterial growth. . First, the useful ingredient Sepicontrol A5 (INCI name: Capryloyl Glycine and Sarcosine and Cinnamomum Zeylanicum Bark Extract) was dissolved in DI water, and then soluble in Glucose / Methyl rapeseedate metabolite of Candida bombicola strain having antibacterial activity against acne-causing strains in ethyl alcohol. After compounding the agent, it is solubilized by addition to the solution. Next, Acnet (INCI name: Water and Butylene Glycol and PEG-60 Almond Glycerides and Caprylyl Glycol and Glycerine and Carbomer and Nordihydroguaiaretic Acid and Oleanolic Acid) is added and dissolved to finally release excess sebum and skin diseases such as acne. Make a cosmetic composition having a therapeutic effect. The composition is basically composed of components having antibacterial activity. Sepicontrol A5 and Acnet show excellent antimicrobial activity against Propionibacterium acnes , which is considered as the main cause of acne, and in the present invention, the effect shows synergistic effect with other components, which is an antibiotic erythromycin. (Erythtomycin) or Clindamycin was larger than.

피지가 과다 분비되는 과정을 살펴보면 5α Reductase 의 중요성은 뚜렷하게 나타난다. 남성 호르몬의 과다한 생성과 5α Reductase의 이상 작용은 피지의 과다한 분비로 이어져 결국에는 여드름의 발생 뿐만 아니라 여드름의 악화 및 지루성 피부염의 발생 등에도 많은 영향을 끼친다. 이에 본 발명은 5α Reductase 를 저해하여 결과적으로 피지의 과다분비를 막아 여드름의 발생과 악화 및 이로 인한 지루성 피부염 등을 줄여주는 특성을 가진 화장료 조성물이다. 또한 휘치헤이즐 추출물, Iricalmin(INCI name : Water, Wheat Germ Extract, Saccharomyces Cerevisiae Extract, Sodium Hyaluronate) 등을 처방함으로써 천연 항균 성분에 의한 피부자극을 최소화 시켰다. 본 발명을 통하여 1차적으로는 피부 여드름 발생 및 피부 염증에 관여하는 미생물의 성장 및 생장을 억제함으로써 그 효과를 나타내었으며 2차적으로는 여드름 발생의 원인 중의 하나인 과잉 피지 분지를 억제함으로써 피부 청결 및 피부 지루의 문제를 해결하였다. 또한 기존의 여드름용 화장료 조성물이 고함량의 알코올성분을 함유하여 심한 자극이나 역한 냄새를 나타냈던 것에 비해 부담 없이 사용할 수 있는 장점도 있다. 실제로 이러한 처방으로 구성된 조성물로 In vitro Test 결과 우수한 항균 작용을 보였으며, 여드름 환자를 대상으로 한 인체 실험에서도 대다수의 여드름 환자에게서 도포 전과 도포 후에 증상에 있어서 뚜렷한 개선을 나타내었다. 또한 피지 분비량에 있어서도 도포 전과 도포 후에 뚜렷한 차이를 보임으로써 피지분비에 있어서 확실한 효과가 있는 것으로 밝혀졌다. 특히 여드름의 치료에는 장기적인 사용이 요구되는 점에서 항생제나 스테로이드와 같은 성분이 배합된 조성물의 경우 내성 및 피부 위축과 같은 부작용을 나타낼 수 있지만 본 발명은 우수한 효과를 나타내면서도 이러한 부작용을 배제할 수 있는 장점이 있다.In the process of sebum oversecretion, the importance of 5α Reductase is clearly shown. Excessive production of testosterone and abnormal effects of 5α reductase leads to excessive secretion of sebum, which eventually affects not only the occurrence of acne but also the deterioration of acne and seborrheic dermatitis. Accordingly, the present invention is a cosmetic composition having the property of inhibiting 5α Reductase and consequently preventing excessive secretion of sebum to reduce the occurrence and exacerbation of acne and seborrheic dermatitis. It also minimizes skin irritation caused by natural antibacterial ingredients by prescribing Witch Hazel Extract, Iricalmin (INCI name: Water, Wheat Germ Extract, Saccharomyces Cerevisiae Extract, Sodium Hyaluronate). Through the present invention, the primary effect was shown by inhibiting the growth and growth of microorganisms involved in skin acne development and skin inflammation, and secondly by inhibiting excess sebum branch which is one of the causes of acne. It solved the problem of skin seborrhea. In addition, the conventional acne cosmetic composition also contains a high content of alcohol component has the advantage that can be used without burden compared to the severe irritation or inverse smell. In fact, in vitro tests showed excellent antimicrobial activity with the composition consisting of these prescriptions, and in the human experiments on acne patients, the majority of acne patients showed clear improvement in symptoms before and after application. In addition, it was found that there is a definite effect on sebum secretion by showing a clear difference in the amount of sebum secretion before and after application. In particular, the treatment of acne requires long-term use, so that the composition containing the antibiotics or steroids may have side effects such as resistance and skin atrophy, but the present invention can exhibit such excellent effects but can exclude these side effects. There is an advantage.

여드름, 피지, 과잉 피지 분비, 항균능, 항균작용, 부작용, 여드름 치료제, Propionibacterium acnes, 지성 피부, 지루성 피부, 여드름성 피부, 지루, 5α Reductase, 남성 호르몬, 활성형 남성 호르몬(DHT), 항생제, 스테로이드Acne, sebum, excess sebum secretion, antibacterial activity, antibacterial effect, side effects, acne treatment, Propionibacterium acnes, oily skin, seborrheic skin, acne skin, seborrhea, 5α Reductase, testosterone, active male hormone (DHT), antibiotic, steroid

Description

피부 표면에 도포 되어 항균 및 과잉 피지 분비 억제 작용에 의해 여드름성 피부, 지루성 피부 등의 개선에 도움을 주는 화장료 조성물 및 그의 제조 방법{Cosmetic Products and their manufacturing methods helping to improve acnegenic and seborrheic skin through anti-microbial action and inhibitory action of sebum secretion.}Cosmetic composition and its manufacturing method which helps to improve acne skin, seborrheic skin by antibacterial and excessive sebum secretion action applied to the surface of skin microbial action and inhibitory action of sebum secretion.}

[도 1] 은 Propionibacterium acnes(ATTC No. : 6919), Staphylococcus pyogens(ATTC No. : 21059), Staphylococcus aureus(ATTC No. : 6538), Escherichia coli(ATTC No. : 8739), Staphylococcus epidermis(ATTC No. : 12228) 균주에 대하여 본 발명에 따라 제조된 화장료 조성물과 비교예 1, 2, 3에 따라 제조된 조성물에 대한 항균능 시험 결과 사진이다. A(실시예 3)는 본 발명에 의한 화장료 조성물, B(비교예 1)는 대조군, C(비교예 2)는 Erythromycin, D(비교예 3)는 Clindamycin의 항균력을 의미한다.1 shows Propionibacterium acnes (ATTC No .: 6919), Staphylococcus pyogens (ATTC No .: 21059), Staphylococcus aureus (ATTC No .: 6538), Escherichia coli (ATTC No .: 8739), Staphylococcus epidermis (ATTC No. : 12228) It is a photograph of the antimicrobial activity test results for the cosmetic composition prepared according to the present invention and the composition prepared according to Comparative Examples 1, 2 and 3. A (Example 3) is a cosmetic composition according to the present invention, B (Comparative Example 1) is a control group, C (Comparative Example 2) is Erythromycin, D (Comparative Example 3) means the antibacterial activity of Clindamycin.

본 발명은 피부 표면에 도포됨으로써 5α Reductase 의 활성을 저해하여 과잉피지 분비를 막고 피부 병면 중에 미생물에 의한 세균 성장을 억제 및 살균하여 피부 여드름 개선 및 과잉 피지 분비로 인한 피부 질환에 효과를 나타내는 화장료 조성물 및 그의 제조방법에 관한 것이다. 본 발명을 통하여 1차적으로는 피부 여드름 발생 및 피부 염증에 관여하는 미생물의 성장 및 생장을 억제함으로써 그 효과를 나타내었으며, 2차적으로는 여드름 발생의 원인 중의 하나인 과잉 피지 분지를 억제함으로써 피부 청결 및 피부 지루의 문제를 해결하였다. 또한 기존의 여드름용 화장료 조성물이 고함량의 알코올성분을 함유하여 심한 자극이나 역한 냄새를 나타냈던 것에 비해 부담없이 사용할 수 있는 장점도 있다. 또한 자극 완화제로서 Iricalmin 등을 처방하여 피부 자극 및 부작용의 가능성을 더욱 줄였다. 대게 여드름은 안면 부위 뿐만 아니라 등, 가슴에 발생되며 이러한 원인으로는 테스토스테론이란 남성 호르몬의 과다한 생성과 5α Reductase의 이상 작용으로 인한 피지의 과잉분비, 각질의 과각질화에 의한 모공의 막힘 및 그에 따른 유해 미생물의 번식 등이 있다. 5α Reductase는 남성 호르몬인 테스토스테론을 활성형 남성 호르몬인 디히드로테스토스테론(DHT)로 전환시키는 인체효소이다. 본 발명은 5α Reductase의 이러한 활성을 억제시켜 모낭세포의 피지 생성 및 각질세포의 과각질화 등을 근원적으로 억제하여 여드름성 피부나 지루성 피부 등을 개선시켜 주는 효과를 나타낸다.The present invention is applied to the skin surface to inhibit the activity of 5α Reductase to prevent excess sebum secretion and inhibiting and sterilizing bacterial growth caused by microorganisms during skin lesions to improve the skin acne and cosmetic effects of the skin disease caused by excess sebum secretion And a method for producing the same. Through the present invention, the primary effect was shown by inhibiting the growth and growth of microorganisms involved in skin acne development and skin inflammation, and secondly, the skin cleanliness by inhibiting excess sebum branch, which is one of the causes of acne. And solved the problem of skin seborrhea. In addition, the conventional acne cosmetic composition has a high content of alcohol components and has the advantage that can be used casually as compared to exhibiting severe irritation or inverse smell. In addition, as a irritant, Iricalmin was prescribed to further reduce the possibility of skin irritation and side effects. Acne usually occurs not only on the facial area but also on the back and chest. These causes include testosterone, an excess of sebum produced by the excessive production of testosterone and abnormal effects of 5α Reductase, clogging of pores due to keratinization and its harmful effects. Microbial propagation. 5α Reductase is a human enzyme that converts testosterone, a male hormone, to dihydrotestosterone (DHT), an active male hormone. The present invention inhibits this activity of 5α Reductase, thereby fundamentally inhibiting sebum production and keratinization of keratinocytes, thereby improving acne skin and seborrheic skin.

현재 이러한 여러 가지의 요인들의 복합적인 작용으로 발생하는 여드름에 대하여 다양한 치료법이 이루어지고 있다. 대표적인 치료법으로는 강산성을 띠는 물질을 이용하여 각질을 녹이는 방식의 각질제거제에 의한 방법, 여드름이 난 부위에 직접 발라 지방 유리산을 제거해주는 방법, 항생물질(Erythromycin, Clindamycin) 의 도포에 의한 방법, 여드름 균에 항균 작용을 가지는 Benzoyl peroxide, 면포 형성을 억제하여 이미 나와 있는 면포수를 줄이는 비타민 A 유도체 등을 피부에 도포하는 방법, 경구용 항생제를 복용하는 것, 스테로이드계 약물을 이용하는 방법, 레이져를 이용하는 것 등의 여러 가지 방법들이 행해지고 있다. 하지만 이들 치료법들은 약물 및 물리적인 방법에 의한 치료법으로서 장시간 시행하면 여러 가지 부작용을 일으킬 소지가 있다. 특히 항생물질이나 스테로이드계 약물에 의한 방법은 체내에서 축척되거나 내성이 생기는 심각한 문제를 일으킬 수 있다. 또한 약물에 의한 각질제거나 레이져 등을 통한 물리적인 각질 제거의 경우 자주 시술되거나 혹은 오랜 기간 사용될 경우 실핏줄이 터지거나 표피층이 약해지는 등 여러 가지 부작용을 가지고 있다. 또한 위와 같은 시술은 한번 만에 되는 것이 아니라 몇 번이고 반복해서 받아야 하는 문제점으로 번거로움 뿐만 아니라 그에 따른 비용적인 측면에 있어서 소비자들에게 부담을 준다. 그와는 상반되는 개념으로 본 발명의 화장료 조성물은 여러 가지 여드름 및 지루성 피부에 효과적인 성분들의 시너지 효과에 의해 피부에 부담을 주지 않으면서 항여드름, 항지루 효과를 극대화 시켜 지속적으로 여드름과 지루성 피부를 관리, 여드름 재발 및 지루성 피부염을 개선할 수 있는 큰 장점이 있다.Currently, various treatments have been made for acne caused by a combination of these various factors. Representative treatments include the use of exfoliants that dissolve keratin using strongly acidic substances, the removal of fatty free acids directly on acne-prone areas, and the application of antibiotics (Erythromycin, Clindamycin). , Benzoyl peroxide which has antibacterial action against acne bacteria, Vitamin A derivative which reduces the number of cotton cloths by inhibiting the formation of cotton cloth, etc., applied to the skin, taking oral antibiotics, using steroid drugs, laser Various methods, such as using a. However, these therapies are drugs and physical treatments that can cause various side effects when administered for a long time. In particular, antibiotics or steroid-based drugs can cause serious problems that build up or build up in the body. In addition, in the case of physical exfoliation using a keratin drug or a laser by the drug, it often has a number of side effects, such as a rupture of the blood vessel or weakening of the epidermal layer when used for a long time. In addition, the above procedure is not a one-time, but a problem that must be repeatedly received many times, as well as a burden on the consumer in terms of cost and the resulting cost. On the contrary, the cosmetic composition of the present invention maximizes anti-acne and anti-seborrheic effect by maximizing anti acne and seborrheic effect without burdening the skin by synergistic effects of various ingredients effective on acne and seborrheic skin. There are great benefits that can improve care, acne recurrence and seborrheic dermatitis.

본 발명은 상기의 피부에 대한 부작용, 소비자들의 부담, 사용상의 어려움 등의 문제점을 해결함과 동시에 피지과다분비로 인한 여드름의 발생 및 악화, 지루성 피부염을 예방하는데 도움을 준다. 또한 항여드름 및 항균 효과를 극대화 시키 기 위하여 여드름 균주에 대해 항균 효과를 가지는 것으로 보고된 성분들과 피부에 악영향을 주는 기타 균주들에 효과적인 항균력을 나타내는 성분을 조합하여 이를 여드름 피부 및 지루성 피부에 적용한 결과 알려진 다른 치료법에 비하여 탁월한 효과가 있다는 결과를 발견하여 본 발명을 완성하게 되었다. 이에 본 발명은 일반 화장료 조성물로써 성별, 연령대의 제한 없이 범용적으로 장기간 사용 가능하며 특히 여드름 및 지루성 피부로 고민하는 사람들에게 우수한 항균력 및 과잉 피지 분비 억제 효과, 자극 없는 사용감을 통하여 도움을 주는 화장료 조성물을 제공하는데 그 목적이 있다고 하겠다.The present invention solves the problems such as side effects on the skin, burden on the consumer, difficulty in use, and at the same time helps to prevent the occurrence and exacerbation of acne due to sebum oversecretion, seborrheic dermatitis. In addition, in order to maximize the anti-acne and antimicrobial effect, a combination of the components reported to have an antimicrobial effect against acne strains and the components that show an effective antimicrobial activity against other strains that adversely affect the skin and apply it to acne skin and seborrheic skin Results The results have been found to be superior to other known therapies to complete the present invention. Therefore, the present invention is a general cosmetic composition can be used universally for a long time without restriction of sex and age, especially for those who suffer from acne and seborrheic skin, excellent antibacterial and excessive sebum secretion effect, a cosmetic composition that helps through a feeling without irritation The purpose is to provide.

본 발명은 여드름성 및 지루성 피부에 대해 효과적인 성분을 함유하는 화장료 조성물에 있어서 정제수 및 보습제(1.3-Butylene Glycol, Glycerine, Sodium Hyaluronate), Ethyl Alcohol 의 부형체 내에 Sepicontrol A5(INCI name : Capryloyl Glycine and Sarcosine and Cinnamomum Zeylanicum Bark Extract), Acnet(INCI name: Water and Butylene Glycol and PEG-60 Almond Glycerides and Caprylyl Glycol and Glycerine and Carbomer and Nordihydroguaiaretic Acid and Oleanolic Acid), Candida bombicola 균주의 Glucose/Methyl rapeseedate 대사산물, Iricalmin (INCI name : Water, Wheat Germ Extract, Saccharomyces Cerevisiae Extract, Sodium Hyaluronate)이 분산되어 있는 여드름 개선용 화장료 조성물을 그 특징으로 한다.The present invention is a cosmetic composition containing an effective ingredient for acne and seborrheic skin Sepicontrol A5 (INCI name: Capryloyl Glycine and Sarcosine) in the excipient of purified water and humectants (1.3-Butylene Glycol, Glycerine, Sodium Hyaluronate), Ethyl Alcohol and Cinnamomum Zeylanicum Bark Extract), Acnet (INCI name: Water and Butylene Glycol and PEG-60 Almond Glycerides and Caprylyl Glycol and Glycerine and Carbomer and Nordihydroguaiaretic Acid and Oleanolic Acid), Glucose / Methyl rapeseedate metabolite of Candida bombicola strain, Iricalmin ( INCI name: Water, Wheat Germ Extract, Saccharomyces Cerevisiae Extract, Sodium Hyaluronate) is characterized by a cosmetic composition for improving acne.

이러한 상기 조성물은 에탄올 3.0∼20.0 중량%, Sepicontrol A5(INCI name : Capryloyl Glycine and Sarcosine and Cinnamomum Zeylanicum Bark Extract) 0.1∼10.0 중량%, Acnet(INCI name: Water and Butylene Glycol and PEG-60 Almond Glycerides and Caprylyl Glycol and Glycerine and Carbomer and Nordihydroguaiaretic Acid and Oleanolic Acid) 0.1-10.0 중량%, Candida bombicola 균주의 Glucose/Methyl rapeseedate 대사산물 0.01∼5.0 중량%, Iricalmin (INCI name : Water, Wheat Germ Extract, Saccharomyces Cerevisiae Extract, Sodium Hyaluronate) 0.1∼10.0 중량%, 정제수 40.0~90.0 중량%가 함유되어 있다.또한 본 발명의 바람직한 제조 방법으로는, Sepicontrol A5(INCI name : Capryloyl Glycine and Sarcosine and Cinnamomum Zeylanicum Bark Extract) 를 정제수에 용해시켜 가온 가용화하는 단계,The composition is 3.0 to 20.0 wt% ethanol, Sepicontrol A5 (INCI name: Capryloyl Glycine and Sarcosine and Cinnamomum Zeylanicum Bark Extract) 0.1 to 10.0 wt%, Acnet (INCI name: Water and Butylene Glycol and PEG-60 Almond Glycerides and Caprylyl Glycol and Glycerine and Carbomer and Nordihydroguaiaretic Acid and Oleanolic Acid) 0.1-10.0 wt%, 0.01-5.0 wt% Glucose / Methyl rapeseedate metabolite of Candida bombicola strain, Iricalmin (INCI name: Water, Wheat Germ Extract, Saccharomyces Cerevisiae Extract, Sodium Hyaluronate) from 0.1 to 10.0% by weight and purified water from 40.0 to 90.0% by weight. In a preferred method of the present invention, Sepicontrol A5 (INCI name: Capryloyl Glycine and Sarcosine and Cinnamomum Zeylanicum Bark Extract) is dissolved in purified water. Warming solubilizing,

별도의 용해조에서 Candida bombicola 균주의 Glucose/Methyl rapeseedate 대사산물을 Ethyl Alcohol에 용해시키는 단계, Dissolving Glucose / Methyl rapeseedate metabolite of Candida bombicola strain in Ethyl Alcohol in a separate dissolution tank,

상기 준비된 1), 2) 에 Iricalmin (INCI name : Water, Wheat Germ Extract, Saccharomyces Cerevisiae Extract, Sodium Hyaluronate), Acnet(INCI name: Water and Butylene Glycol and PEG-60 Almond Glycerides and Caprylyl Glycol and Glycerine and Carbomer and Nordihydroguaiaretic Acid and Oleanolic Acid) 을 첨가 분산 시킨 다음 여과시키는 단계를 포함하는 것을 특징으로 한다. 이러한 제조방법에서 상기 1), 2)의 각 단계에 향, 방부제 및 또 다른 유효성분 중에서 선택된 1종 이상을 첨가하여 혼합시키는 단계를 추가로 포함할 수 있다.Iricalmin (INCI name: Water, Wheat Germ Extract, Saccharomyces Cerevisiae Extract, Sodium Hyaluronate), Acnet (INCI name: Water and Butylene Glycol and PEG-60 Almond Glycerides and Caprylyl Glycol and Glycerine and Carbomer and Nordihydroguaiaretic Acid and Oleanolic Acid) is characterized in that it comprises the step of further dispersing and filtering. In this manufacturing method, the steps of 1) and 2) may further include mixing by adding one or more selected from fragrances, preservatives and another active ingredient.

이하, 본 발명을 실시예에 의거하여 더욱 상세하게 설명하겠는바, 본 발명이 실시예에 의하여 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited by Examples.

실시예 1Example 1

아래 [표 1]에 나타낸 조성에 따라 제조하였으며, 그 제조 방법은 다음과 같다.It was prepared according to the composition shown in Table 1 below, the preparation method is as follows.

A상의 성분들을 완전 용해시키고 별도의 용해조에서 B상의 성분들을 완전 용해 시킨 다음 B상을 A상에 첨가하여 혼합 가용화 시켰다. 여기에 C상과 D상의 성분들을 순차적으로 첨가하여 혼합 균일화 시킨 다음 여과시켜 본 조성물을 제조하였다.After completely dissolving the components of phase A and completely dissolving the components of phase B in a separate dissolution bath, phase B was added to phase A and mixed solubilized. The components of the C and D phases were added sequentially, homogenized and filtered to prepare the composition.

실시예 2Example 2

상기의 실시예 1에 A상을 섭씨 50도까지 가온하여 제조하였으며, B상을 A상에 첨가하여 혼합 가용화한 후 섭씨 20∼35도 까지 냉각시켜 여기에 C와 D상의 성분들을 순차적으로 혼합 균일화 시킨 다음 여과시켜 본 조성물을 제조하였다.Prepared by heating the A phase to 50 degrees Celsius in Example 1 above, solubilizing the mixture by adding the B phase to the A phase, and then cooled to 20 to 35 degrees Celsius to uniformly mix the components of the C and D phases sequentially And then filtered to prepare the composition.

그 조성은 아래 [표 1] , [표 2] 에 나타내었다.The composition is shown in the following [Table 1] and [Table 2].

실시예 3∼ 10Examples 3-10

상기의 실시예 2와 동일한 제조 방법으로 제조하였다.It manufactured by the same manufacturing method as Example 2 mentioned above.

Figure 112003525368219-pat00001
Figure 112003525368219-pat00001

Figure 112003525368219-pat00002
Figure 112003525368219-pat00002

비교예 1Comparative Example 1

실시예의 경우와 비교하기 위하여 부형제와 항생제가 함유되는 조성물을 각각 제조하였으며, 그 조성비는 아래 [표 3] 에 나타내었다. 제조 방법은 먼저 B상의 성분들을 완전 용해 시킨 다음 A상에 부가 첨가하며 다음으로 C, D상의 성분을 순차적으로 혼합하여 첨가하여 혼합 균일화 시킨 다음 여과시켜 조성물을 제조하였다.In order to compare with the case of the examples were prepared a composition containing an excipient and an antibiotic, respectively, the composition ratio is shown in Table 3 below. In the manufacturing method, first, completely dissolving the components of phase B and then adding them to phase A, and then mixing the components of phases C and D were added sequentially to homogenize mixing, and then filtered to prepare a composition.

비교예 2 ∼ 3Comparative Examples 2 to 3

상기의 비교예 1과 동일한 방법으로 제조하였으며, 그 조성은 다음 표 3에 나타내었다.It was prepared in the same manner as in Comparative Example 1, the composition is shown in Table 3 below.

Figure 112003525368219-pat00003
Figure 112003525368219-pat00003

시험예Test Example

1) 항균력 시험1) Antibacterial test

실시예 1∼10 및 비교예 1∼3의 조성으로 제조된 각각의 화장료 조성물을 여드름 원인 균주인 Propionibacterium acnes, Staphylococcus aureus, Escherichia coli, Staphylococcus pyogensStaphylococcus epidermis 에 대하여 항균력 시험하여 그 결과를 아래 [표 4] 에 나타내었다. 조사법으로는 평원반 평판(Disc Plate)법을 사용하였다. 이 방법은 한천 평판 배지에 Staphylococcus aureus, Escherichia coli, Staphylococcus pyogens, Staphylococcus epidermis 균주 및 Propionibacterium acnes 을 도말한 후 실시예 및 비교예 조성물을 처리한 평원판(Paper Disc)을 올려놓고 배양하여, 생성된 생장 저해 부위(Inhibition Zone)의 크기를 조사함으로써 조성물에 대한 항균력을 조사하였다.Each cosmetic composition prepared in the compositions of Examples 1 to 10 and Comparative Examples 1 to 3 were tested for antimicrobial activity against the acne-causing strains Propionibacterium acnes, Staphylococcus aureus, Escherichia coli, Staphylococcus pyogens and Staphylococcus epidermis . 4]. Disc plate method was used as an irradiation method. In this method , after spreading Staphylococcus aureus, Escherichia coli, Staphylococcus pyogens, Staphylococcus epidermis strain, and Propionibacterium acnes on agar plate medium, a cultured plate was placed on the plate and treated with the composition of Examples and Comparative Examples. The antimicrobial activity of the composition was examined by examining the size of the inhibition zone.

Figure 112003525368219-pat00005
Figure 112003525368219-pat00005

2) 임상시험2) Clinical trial

1. 여드름 환자 대상 임상 실험 결과1. Clinical Trial Results of Acne Patients

여드름 환자 50명을 대상으로 여드름이 발생한 병변 국소 부위를 중심으로 실시예 3과 비교예 3에 의해 만들어진 화장료를 세안 후 하루 두 번 Blind Test 방식을 적용하여 도포한 결과를 아래 [표 5] 에 나타내었다.The results of applying the Blind Test method twice a day after cleansing the cosmetics prepared by Example 3 and Comparative Example 3 mainly on the lesion site where acne occurred in 50 acne patients are shown in [Table 5] below. It was.

Figure 112003525368219-pat00006
Figure 112003525368219-pat00006

상기 [표 5] 에 나타나듯이 실시예 3과 비교예 2, 3에서 모두 여드름 개선에 대해 그 효과가 있음을 알 수 있다. 그러나 사용함에 있어 비교예 2, 3의 경우는 실시예 3에 비해 자극이 강하여 장기적으로 사용하는 것에는 무리가 있을 것 같으며 여드름 재발에 있어서도 비교예 2, 3의 28%와 24%에 비해 실시예 3는 낮은 수준인 18%였다. 따라서, 자극여부 및 정도, 재발 정도, 치유 정도 등의 여러 가지 요소를 객관적인 관점에서 바라볼 때 실시예 3의 경우가 여드름 피부의 환자에게 더욱 적합하다는 결론을 내릴 수 있다.As shown in Table 5, in Example 3 and Comparative Examples 2 and 3, it can be seen that the effect on the improvement of acne. However, in the case of use of Comparative Examples 2 and 3, the stimulus is stronger than that of Example 3, so it may be difficult to use it in the long term. Example 3 was 18% which is a low level. Therefore, it can be concluded that the case of Example 3 is more suitable for patients with acne skin from the objective point of view of various factors such as irritation and severity, degree of recurrence, and degree of healing.

2. 지성, 지루성 피부 대상 임상 실험 결과2. Clinical trial results for oily and seborrheic skin

지성, 지루성 피부의 지원자 50명을 대상으로 안면 부위를 중심으로 실시예 1과 비교예 2, 3에 의해 만들어진 화장료를 세안 후 하루 두 번 Blind Test 방식을 적용하여 도포한 후 피지 분비량 감소에 대한 결과를 아래 [표 6] 에 나타내었다.Results of reduction of sebum secretion after applying the Blind Test method twice a day after cleansing the cosmetics produced by Examples 1 and Comparative Examples 2 and 3, mainly on the facial area, of 50 volunteers with oily or seborrheic skin Is shown in Table 6 below.

Figure 112003525368219-pat00007
Figure 112003525368219-pat00007

상기 [표 6] 의 결과에서 처럼 실시예 1의 경우 비교예 2, 3에 비하여 피지 분비량 감소에서 있어서 탁월한 효과를 나타내었다. 또한 자극 유무에 있어서도 실시예 1의 경우는 비교예 2, 3에 비해 자극이 거의 없어 지속적인 사용이 가능할 것이라 사료된다. 특히 저자극의 우수한 과다 피지 분비 억제 효과는 본 발명의 특징이라 할 수 있다.As in the results of Table 6, Example 1 showed an excellent effect in reducing sebum secretion compared to Comparative Examples 2 and 3. In addition, even in the presence or absence of stimulation, in the case of Example 1 , compared to Comparative Examples 2 and 3, there is almost no stimulation, and it is considered that continuous use is possible. In particular, the excellent effect of inhibiting the secretion of excessive sebum secretion can be said to be a feature of the present invention.

상술한 바와 같이, 본 발명은 여러 가지 피부 유해균 등에 우수한 항균 효과를 나타내며 특히 과잉 피지 분비 억제 효과가 탁월하여 이로 인한 여드름, 지성, 지루성 피부의 트러블을 근원적으로 개선하는데 우수한 효과를 나타낸다.As described above, the present invention exhibits an excellent antibacterial effect on various skin harmful bacteria and the like, and in particular, the effect of inhibiting excessive sebum secretion is excellent, thereby showing an excellent effect in fundamentally improving troubles of acne, oily and seborrheic skin.

현재까지의 지성, 지루성 피부를 가진 사람들에 대한 뚜렷한 케어 방법이 없어 클렌징 등의 방법에 의존하던 화장료들과는 많은 차이가 있다고 할 수 있다.There is no clear way of care for people with oily or seborrheic skin so far, which is different from cosmetics that depended on cleansing and other methods.

또한 저 함량의 알코올을 함유하여 피부자극이 없으면서도 우수한 여드름 치료효과가 입증되어 여드름으로 고생하는 많은 환자들에게 장기 연용 할 수 있는 안전한 형태의 화장료를 공급할 수 있게 되었다. In addition, it contains a low content of alcohol and proves excellent acne treatment without skin irritation, thus providing a safe form of cosmetics that can be used for a long time for many patients suffering from acne.                     

추가적으로 피부과 병원 등을 정기적으로 방문하는 경제적 부담도 줄여준다는 점 등에서 본 발명의 의의를 찾을 수 있다.In addition, the significance of the present invention can be found in that it also reduces the economic burden of regularly visiting dermatology hospitals and the like.

Claims (4)

지성, 지루성, 여드름성 피부 등에 대하여 과다 피지 분비 억제 및 여드름 치유 효과를 가지는 화장료 조성물에 있어서 정제수, Sepicontrol A5(INCI name : Capryloyl Glycine and Sarcosine and Cinnamomum Zeylanicum Bark Extract), Candida bombicola 균주의 Glucose/Methyl rapeseedate 대사산물, Ethyl Alcohol, Iricalmin (INCI name : Water, Wheat Germ Extract, Saccharomyces Cerevisiae Extract, Sodium Hyaluronate), Acnet(INCI name : Water and Butylene Glycol and PEG-60 Almond Glycerides and Caprylyl Glycol and Glycerine and Carbomer and Nordihydroguaiaretic Acid and Oleanolic Acid)이 용해 분산되어 균일화된 구조를 갖는 화장료 조성물.Purified water, Sepicontrol A5 (INCI name: Capryloyl Glycine and Sarcosine and Cinnamomum Zeylanicum Bark Extract), Glucose / Methyl rapeseedate of Candida bombicola strains for cosmetic compositions having excessive sebum secretion and acne healing effect against oily, seborrheic, acne skin, etc. Metabolites, Ethyl Alcohol, Iricalmin (INCI name: Water, Wheat Germ Extract, Saccharomyces Cerevisiae Extract, Sodium Hyaluronate), Acnet (INCI name: Water and Butylene Glycol and PEG-60 Almond Glycerides and Caprylyl Glycol and Glycerine and Carbomer and Nordihydroguaiaretic Acid and Oleanolic Acid) is dissolved and dispersed to have a uniform composition. 제 1항에 있어서, 상기 조성물에는 에탄올 3.0∼20.0 중량%, Sepicontrol A5(INCI name : Capryloyl Glycine and Sarcosine and Cinnamomum Zeylanicum Bark Extract) 0.1∼10.0 중량%, Acnet(INCI name: Water and Butylene Glycol and PEG-60 Almond Glycerides and Caprylyl Glycol and Glycerine and Carbomer and Nordihydroguaiaretic Acid and Oleanolic Acid) 0.1∼10.0 중량%, Candida bombicola 균주의 Glucose/Methyl rapeseedate 대사산물 0.01∼5.0 중량%, Iricalmin (INCI name : Water, Wheat Germ Extract, Saccharomyces Cerevisiae Extract, Sodium Hyaluronate) 0.1∼10.0 중량%, 정제수 40.0∼90.0 중량%이 함 유된 것임을 특징으로 하는 화장료 조성물.According to claim 1, wherein the composition is 3.0 to 20.0% by weight of ethanol, Sepicontrol A5 (INCI name: Capryloyl Glycine and Sarcosine and Cinnamomum Zeylanicum Bark Extract) 0.1 to 10.0% by weight, Acnet (INCI name: Water and Butylene Glycol and PEG- 60 Almond Glycerides and Caprylyl Glycol and Glycerine and Carbomer and Nordihydroguaiaretic Acid and Oleanolic Acid) 0.1~10.0% by weight, Candida bombicola Glucose / Methyl rapeseedate metabolite of strain 0.01~5.0 weight%, Iricalmin (INCI name: Water, Wheat Germ Extract, Saccharomyces Cerevisiae Extract, Sodium Hyaluronate) cosmetic composition characterized in that it contains 0.1 to 10.0% by weight, 40.0 to 90.0% by weight purified water. 지성, 지루성, 여드름성 피부에 치료 효과를 자기는 화장료 조성물 제조하는 방법에 있어서,In the method for producing a cosmetic composition that has a therapeutic effect on oily, seborrheic, acne skin, 1) 정제수에 Sepicontrol A5(INCI name : Capryloyl Glycine and Sarcosine and Cinnamomum Zeylanicum Bark Extract),1) Sepicontrol A5 (INCI name: Capryloyl Glycine and Sarcosine and Cinnamomum Zeylanicum Bark Extract) in purified water, 성분들을 용해시키는 단계 혹은 이를 위해 섭씨 40~60도까지 가온하여 용해시키는 단계Dissolving the ingredients or dissolving them by heating to 40-60 degrees Celsius 2) 별도의 용해조에서 에탄올, Candida bombicola 균주의 Glucose/Methyl rapeseedate 대사산물 성분들을 완전 용해 시키는 단계.2) Complete dissolution of Glucose / Methyl rapeseedate metabolite components of ethanol and Candida bombicola strain in a separate dissolution tank. 3) 상기 준비된 1), 2)에 Acnet(INCI name: Water and Butylene Glycol and PEG-60 Almond Glycerides and Caprylyl Glycol and Glycerine and Carbomer and Nordihydroguaiaretic Acid and Oleanolic Acid), Iricalmin (INCI name : Water, Wheat Germ Extract, Saccharomyces Cerevisiae Extract, Sodium Hyaluronate)을 첨가하여 분산시킨 다음 여과시키는 단계를 포함하는 것을 특징으로 하는 화장료 조성물의 제조 방법.3) Acnet (INCI name: Water and Butylene Glycol and PEG-60 Almond Glycerides and Caprylyl Glycol and Glycerine and Carbomer and Nordihydroguaiaretic Acid and Oleanolic Acid), Iricalmin (INCI name: Water, Wheat Germ Extract) , Saccharomyces Cerevisiae Extract, Sodium Hyaluronate) is added to disperse and then filtered to produce a cosmetic composition comprising the step of filtering. 삭제delete
KR1020030102337A 2003-12-31 2003-12-31 Cosmetic Products and their manufacturing methods helping to improve acnegenic and seborrheic skin through anti-microbial action and inhibitory action of sebum secretion. KR100593707B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020030102337A KR100593707B1 (en) 2003-12-31 2003-12-31 Cosmetic Products and their manufacturing methods helping to improve acnegenic and seborrheic skin through anti-microbial action and inhibitory action of sebum secretion.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020030102337A KR100593707B1 (en) 2003-12-31 2003-12-31 Cosmetic Products and their manufacturing methods helping to improve acnegenic and seborrheic skin through anti-microbial action and inhibitory action of sebum secretion.

Publications (2)

Publication Number Publication Date
KR20050071275A KR20050071275A (en) 2005-07-07
KR100593707B1 true KR100593707B1 (en) 2007-04-12

Family

ID=37261243

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020030102337A KR100593707B1 (en) 2003-12-31 2003-12-31 Cosmetic Products and their manufacturing methods helping to improve acnegenic and seborrheic skin through anti-microbial action and inhibitory action of sebum secretion.

Country Status (1)

Country Link
KR (1) KR100593707B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102506821B1 (en) 2022-11-02 2023-03-08 주식회사 제이피에스코스메틱 Cosmeticswith anti-belmishand anti-acne, and Manufacturing method thereof

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102496013B1 (en) * 2015-11-30 2023-02-06 (주)아모레퍼시픽 Skin external composition containing aralosides
KR101913337B1 (en) * 2016-02-23 2019-02-28 순천향대학교 산학협력단 Composition for improving acne containing kaempferia parviflora
KR102047459B1 (en) 2018-12-24 2019-11-21 한국식품연구원 Lactobacillus plantarum WiKim0088
CN109528523B (en) * 2018-12-28 2021-10-26 蓓悠清(广东)健康科技有限公司 Amino acid facial cleanser
KR102217039B1 (en) * 2019-02-21 2021-02-18 주식회사 유진바이오텍 Composition for improving trichophytia contating wheat germ extract
KR102400146B1 (en) * 2019-10-28 2022-05-20 주식회사 유진바이오텍 A composition for improving acne skin containing wheat germ extract and natural extract as active ingredients.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102506821B1 (en) 2022-11-02 2023-03-08 주식회사 제이피에스코스메틱 Cosmeticswith anti-belmishand anti-acne, and Manufacturing method thereof

Also Published As

Publication number Publication date
KR20050071275A (en) 2005-07-07

Similar Documents

Publication Publication Date Title
US4593046A (en) Method of reducing skin irritation from benzoyl peroxide
WO2008140200A1 (en) External compositions for the skin
KR101018352B1 (en) Composition of comprising bee-venoms for treating acne
KR20140060475A (en) Compositions containing anti-acne agents and the use thereof
KR20080098595A (en) Anti-aging treatment using copper and zinc compositions
EP0621787A1 (en) Skin therapeutic mixture containing cold-processed aloe vera extract, with yellow sap and aloin removed
WO2011119247A2 (en) Topical skincare composition
KR100593707B1 (en) Cosmetic Products and their manufacturing methods helping to improve acnegenic and seborrheic skin through anti-microbial action and inhibitory action of sebum secretion.
KR102115668B1 (en) Cosmetic composition having anti-acne activity comprising probiotics fermentation product
TW201416071A (en) Antiseptic, antiseborrheic and exfoliating composition to remove or prevent acne
CN107519236A (en) A kind of topical agent for treating onychomycosis
JP2014516962A (en) Compositions and methods for the treatment of skin diseases
RU2405534C1 (en) Anti-acne cream gel
KR102293585B1 (en) Wax-type cleanser
EP2386309A1 (en) Bulbine frutescens gel
KR100892742B1 (en) Skin external composition for treating pimple
JP4586178B2 (en) External preparation for improving skin damaged by burns
WO2018229072A1 (en) Composition for preventing hair loss and promoting hair growth
CN114948805B (en) Antibacterial composition containing sweet wormwood volatile oil and application of antibacterial composition in acne-removing skin care product
CN115624520B (en) Diosmin cream and application thereof
JP6853406B1 (en) Topical composition for antifolliculitis
WO2024012386A1 (en) Composition containing artemisia annua l. extract and oil-soluble component, and use thereof
KR102329748B1 (en) Wax-type cleanser improving problematic skin
JP2004307372A (en) External preparation for acne, use of plum extract and germicidal and antibacterial agent
JP2001206820A (en) Preparation for external use for treating acne

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120425

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20130610

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20141208

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20150622

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20160613

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20170602

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20180614

Year of fee payment: 13